Shin Mineishi, MD
Penn State Cancer Institute (Hershey Medical Center) · University of Alabama at Birmingham
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shin Mineishi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:07 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03709576 · Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AMLMilton S. Hershey Medical Center · terminated · Acute Myeloid Leukemia (AML) · principal investigator
- Ph2NCT01457885 · Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 RegimenUniversity of Michigan Rogel Cancer Center · completed · Acute Myeloblastic Leukemia · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.